Invizius gets MHRA Approval for H-Guard research
First-in-human study to be undertaken at the Manchester University Hospitals NHS Foundation Trust
Read More
Tag: invizius
Invizius’ ‘angry blood’ research recruits 300th patient
525-patient trial intends to assess ‘complement activation’ during HD in patients with end stage renal failure
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
